^
    Apply
    INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas (NCT04295759)
    Phase 1
    Pediatric Brain Tumor Consortium
    Completed
    Last update posted :
    02/19/2025
    Initiation :
    07/27/2020
    Primary completion :
    12/31/2023
    Completion :
    12/01/2024
    HER-2 • CD4 • ADAM10
    |
    aderbasib (INCB7839)
    Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors (NCT00820560)
    Phase 1
    Incyte Corporation
    Completed
    Last update posted :
    01/17/2018
    Initiation :
    01/01/2005
    Primary completion :
    01/01/2009
    Completion :
    01/01/2009
    HER-2
    |
    aderbasib (INCB7839)